Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kristl Claeys

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Frontiers in Neurology|February 20, 2024
Editorial: Implementing new technologies for neuromuscular disordersNicolas Dubuisson, Kristl Claeys, Benedikt Schoser
European Journal of Case Reports in Internal Medicine|November 13, 2025
When the Diaphragm Fails: Visual Hallucinations Due to Isolated Respiratory Muscle Weakness as a First Manifestation of Late-Onset Pompe DiseaseCaroline Van Lierde, Mathieu Brancaleone, Tom Cornelis, et al.
Acta Clinica Belgica|December 22, 2019
Papillary thyroid carcinoma presenting with severe Guillain-Barré syndromeMaarten Van Hemelen, Kristl Claeys, Philip Van Damme, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|August 1, 2020
Diagnostic yield of testing for <i>RFC1</i> repeat expansions in patients with unexplained adult-onset cerebellar ataxiaSien Hilde Van Daele, Sascha Vermeer, Amélie Van Eesbeeck, et al.
Neuropsychologia|December 14, 2005
Mapping the parietal cortex of human and non-human primatesGuy A Orban, Kristl Claeys, Koen Nelissen, et al.
Neurology|February 20, 2025
Effect Size Analysis of Cipaglucosidase Alfa Plus Miglustat Versus Alglucosidase Alfa in ERT-experienced Adults with Late-onset Pompe Disease in PROPEL (S21.003)Hani Kushlaf, Drago Bratkovic, Barry Byrne, et al.
Nature Genetics|February 26, 2005
Mutations in the pleckstrin homology domain of dynamin 2 cause dominant intermediate Charcot-Marie-Tooth diseaseStephan Züchner, Maher Noureddine, Marina Kennerson, et al.
Science Translational Medicine|April 21, 2017
Improving genetic diagnosis in Mendelian disease with transcriptome sequencingBeryl B Cummings, Jamie L Marshall, Taru Tukiainen, et al.
Journal of Neuromuscular Diseases|November 14, 2022
Telemedicine in Neuromuscular Diseases During Covid-19 Pandemic: ERN-NMD European SurveyLynda El-Hassar, Ahmed Amara, Benoit Sanson, et al.
Journal of Neurology|February 13, 2024
Correction to: Analysis of muscle magnetic resonance imaging of a large cohort of patient with VCP‑mediated disease reveals characteristic features useful for diagnosisDiana Esteller, Marianela Schiava, José Verdú-Díaz, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Frontiers in Neurology|February 20, 2024
Editorial: Implementing new technologies for neuromuscular disordersNicolas Dubuisson, Kristl Claeys, Benedikt Schoser
European Journal of Case Reports in Internal Medicine|November 13, 2025
When the Diaphragm Fails: Visual Hallucinations Due to Isolated Respiratory Muscle Weakness as a First Manifestation of Late-Onset Pompe DiseaseCaroline Van Lierde, Mathieu Brancaleone, Tom Cornelis, et al.
Acta Clinica Belgica|December 22, 2019
Papillary thyroid carcinoma presenting with severe Guillain-Barré syndromeMaarten Van Hemelen, Kristl Claeys, Philip Van Damme, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|August 1, 2020
Diagnostic yield of testing for <i>RFC1</i> repeat expansions in patients with unexplained adult-onset cerebellar ataxiaSien Hilde Van Daele, Sascha Vermeer, Amélie Van Eesbeeck, et al.
Neuropsychologia|December 14, 2005
Mapping the parietal cortex of human and non-human primatesGuy A Orban, Kristl Claeys, Koen Nelissen, et al.
Neurology|February 20, 2025
Effect Size Analysis of Cipaglucosidase Alfa Plus Miglustat Versus Alglucosidase Alfa in ERT-experienced Adults with Late-onset Pompe Disease in PROPEL (S21.003)Hani Kushlaf, Drago Bratkovic, Barry Byrne, et al.
Nature Genetics|February 26, 2005
Mutations in the pleckstrin homology domain of dynamin 2 cause dominant intermediate Charcot-Marie-Tooth diseaseStephan Züchner, Maher Noureddine, Marina Kennerson, et al.
Science Translational Medicine|April 21, 2017
Improving genetic diagnosis in Mendelian disease with transcriptome sequencingBeryl B Cummings, Jamie L Marshall, Taru Tukiainen, et al.
Journal of Neuromuscular Diseases|November 14, 2022
Telemedicine in Neuromuscular Diseases During Covid-19 Pandemic: ERN-NMD European SurveyLynda El-Hassar, Ahmed Amara, Benoit Sanson, et al.
Journal of Neurology|February 13, 2024
Correction to: Analysis of muscle magnetic resonance imaging of a large cohort of patient with VCP‑mediated disease reveals characteristic features useful for diagnosisDiana Esteller, Marianela Schiava, José Verdú-Díaz, et al.
Pageof 2